Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eremin

Showing results (31-40 of 1,013) with videos related to

Pageof 102
Sort By:
Membranes|September 27, 2023
Dimensional Transformation of Percolation Structure in Mixed-Matrix Membranes (MMMs)Alexey Grekhov, Yury Eremin
Nuclear Medicine Communications|December 18, 2004
Monitoring the response of large (>3 cm) and locally advanced (T3-4, N0-2) breast cancer to neoadjuvant chemotherapy using (99m)Tc-Sestamibi uptakeChristopher Marshall, Jennifer Eremin, Mohammed El-Sheemy, et al.
Journal of the Royal College of Surgeons of Edinburgh|August 2, 2001
Dendritic cells (II): Role and therapeutic implications in cancerS Satthaporn, O Eremin
Applied Optics|December 4, 2010
Simulation of light scattering from a particle upon a wafer surfaceY Eremin, N Orlov
Physical Review Letters|February 7, 2007
Comment on "Spin dynamics of the electron-doped high-Tc superconducting cuprates"Thomas Dahm, Ilya Eremin
Physical Review Letters|March 24, 2005
Fermi-liquid-based theory for the in-plane magnetic anisotropy in untwinned high-Tc superconductorsI Eremin, D Manske
Springerplus|May 22, 2015
Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survivalJennifer Eremin, Ged Cowley, Leslie G Walker, et al.
BMC Cancer|February 3, 2018
Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NACViriya Kaewkangsadan, Chandan Verma, Jennifer M Eremin, et al.
Journal of Immunology Research|October 26, 2016
Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast CancerViriya Kaewkangsadan, Chandan Verma, Jennifer M Eremin, et al.
Cancer Cell International|May 31, 2012
The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cellsNeil D Jelly, Issam I Hussain, Jennifer Eremin, et al.
Pageof 102

Showing results (31-40 of 1,013) with videos related to

Sort By:
Pageof 102
Membranes|September 27, 2023
Dimensional Transformation of Percolation Structure in Mixed-Matrix Membranes (MMMs)Alexey Grekhov, Yury Eremin
Nuclear Medicine Communications|December 18, 2004
Monitoring the response of large (>3 cm) and locally advanced (T3-4, N0-2) breast cancer to neoadjuvant chemotherapy using (99m)Tc-Sestamibi uptakeChristopher Marshall, Jennifer Eremin, Mohammed El-Sheemy, et al.
Journal of the Royal College of Surgeons of Edinburgh|August 2, 2001
Dendritic cells (II): Role and therapeutic implications in cancerS Satthaporn, O Eremin
Applied Optics|December 4, 2010
Simulation of light scattering from a particle upon a wafer surfaceY Eremin, N Orlov
Physical Review Letters|February 7, 2007
Comment on "Spin dynamics of the electron-doped high-Tc superconducting cuprates"Thomas Dahm, Ilya Eremin
Physical Review Letters|March 24, 2005
Fermi-liquid-based theory for the in-plane magnetic anisotropy in untwinned high-Tc superconductorsI Eremin, D Manske
Springerplus|May 22, 2015
Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survivalJennifer Eremin, Ged Cowley, Leslie G Walker, et al.
BMC Cancer|February 3, 2018
Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NACViriya Kaewkangsadan, Chandan Verma, Jennifer M Eremin, et al.
Journal of Immunology Research|October 26, 2016
Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast CancerViriya Kaewkangsadan, Chandan Verma, Jennifer M Eremin, et al.
Cancer Cell International|May 31, 2012
The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cellsNeil D Jelly, Issam I Hussain, Jennifer Eremin, et al.
Pageof 102